Safer Minimally Invasive Treatments in High-Risk & Comorbid Patients with Prostate Enlargement (BPH)
Prostate enlargement, which is called Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement and is common in ...
In data supporting FDA approval, 48.1% implanted with Prodeon’s Urocross saw International Prostate Symptom Score ...
Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic diseases, today announced it has received U.S. Food and Drug Administration (FDA ...
Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic diseases, today announced it has received U.S. Food and Drug Administration (FDA ...
Procept BioRobotics today announced the international rollout of its next-generation Hydros robotic system for Aquablation therapy.
PROCEPT BioRobotics (Nasdaq: PRCT), today announced the international expansion of the HYDROS Robotic System, the company’s next-generation platform for delivering Aquablation therapy to treat benign ...
Newspoint on MSN
Enlarged prostate symptoms: These 5 signs after the age of 40 are a warning sign for men, as the prostate enlarges
Prostate Enlargement Treatment: Prostate problems are increasing rapidly in men. Let us tell you which major signs should not be ignored after 40 and when should you consult a doctor? What are the ...
Men from across Surrey are set to benefit from a major investment in leading medical technology at Nuffield Health Woking Hospital, as the hospital launches Aquablation therapy for patients suffering ...
A prescription medication that has been available in the U.S. since 1992 might have another significant benefit.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results